Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

Short summary

European guidelines recommend established systemic immunosuppressants (cyclosporine, methotrexate, azathioprine, mycophenolic acid) for severe refractory atopic eczema, with biologics like dupilumab as a safe and effective alternative. Antimicrobial therapy is advised for superinfections, and allergen-specific immunotherapy may be considered for selected cases. Psychosomatic counselling and patient education ('Eczema school') are also recommended.

AI-generated from the title and abstract; the full text is not read.